Given the dosage-sensitive nature of CRHR1 expression, we focused our analysis on CNVs rather than SNPs to capture structural changes with potentially greater physiological impact. In this study, we examined whether CNVs in the CRHR1 gene may underlie the depressive symptoms and cognitive impairment observed following SARS-CoV-2 infection. This evidence concerns the gene CRHR1 and Cognitive impairment.